Ten-year follow-up after initiation of statin therapy in children with familial hypercholesterolemia

JAMA - Journal of the American Medical Association

Volumn 312, Issue 10, 2014, Pages 1055-1057

  Kusters, D Meeike ^a   Avis, Hans J ^a   De Groot, Eric ^b   Wijburg, Frits A ^a   Kastelein, John J P ^a   Wiegman, Albert ^a   Hutten, Barbara A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PRAVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID;

ADOLESCENT; ADULT; ARTERIAL WALL THICKNESS; BLOOD SAMPLING; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILY HISTORY; FEMALE; FOLLOW UP; HETEROZYGOSITY; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PHYSICAL EXAMINATION; RANDOMIZED CONTROLLED TRIAL; RHABDOMYOLYSIS; SCHOOL CHILD; ARTICLE; BLOOD; CONTROLLED CLINICAL TRIAL; STATISTICAL MODEL;

ADOLESCENT; CAROTID INTIMA-MEDIA THICKNESS; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPOPROTEINEMIA TYPE II; LINEAR MODELS; LIPIDS; MALE; PRAVASTATIN;

EID: 84907008306     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.8892     Document Type: Letter

References (6)

1. Marks D, Thorogood M, Neil HA, Humphries SE. A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia. Atherosclerosis. 2003;168(1):1-14.
2. Wiegman A, de Groot E, Hutten BA, et al. Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia. Lancet. 2004;363 (9406):369-370.
3. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics. 2011;128 (suppl 5):S213-S256.
4. Wiegman A, Hutten BA, de Groot E, et al. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. JAMA. 2004;292(3):331-337.
5. de Groot E, Hovingh GK, Wiegman A, et al. Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation. 2004;109(23) (suppl 1):III33-III38.
6. Baigent C, Keech A, Kearney PM, et al Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospectivemeta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366(9493):1267-1278.